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ABSTRACT: Studies on experimental infection of Leishmania aethiopica are very limited due to lack 
of laboratory animal models. It was previously reported that the African green monkey (grivet 
monkey) could serve as a non–human primate model of L. aethiopica infection. This report provides 
preliminary data on the development and progression of skin lesions in grivet monkeys when 
infected with L. aethiopica either in the eye lids or the tip of nose. A total of 22 African green 
monkeys were inoculated subcutaneously on the eye lid (n=14) or the tip of nose (n=8) with 5 x 106   
stationary phase promastigotes of L. aethiopica. No lesions developed on the eye lids. Lesions of 
various stages of cutaneous leishmaniasis were observed at the tip of nose. The outcome of L. 
aethiopica infection in African green monkeys and possibly humans could be infection-site 
dependent. Further studies are needed to examine and understand the immunopathogenetic 
processes.  
 





Cutaneous leishmaniasis caused by Leishmania 
aethiopica is an endemic disease in Ethiopia. The 
disease has three clinical forms: localized cutane-
ous leishmaniasis (LCL), diffused cutaneous 
leishmaniasis (DCL) and mucocutaneous leishma-
niasis (MCL).  LCL is mostly seen as self-healing 
single lesions in parts of the body not covered by 
clothing e.g., the  face, arms and legs (WHO, 2010). 
DCL shows multiple lesions on the face, torso and 
extremities and is usually not self–healing. MCL 
(Padovese et al., 2009) may result in distortion of 
nostrils and lips. The most dominant form is LCL; 
whereas DCL and MCL are less frequent (WHO, 
2010).  
 Animal models are vital in the search of 
vaccine and drugs for the control of diseases. The 
availability of an experimental model system for 
L. major, L. tropica, L. infantum and  L. braziliensis 
allowed the explanation of some of the different 
mechanisms involved in these infections 
(Latorre–Esteves et al., 2010; Roque et al., 2010; 
Souza–Lemos et al., 2011; Silva et al., 2012). Non–
human primates such as African green monkeys 
are also used as an animal model (Gicheru et al., 
2009; Mutiso et al., 2012). The utilization of non–
human primates susceptible to CL has its advan-
tages because of their phylogenetic closeness to 
man. Studies on L. aethiopica are restricted due to 
the lack of suitable animal model. Several 
attempts, carried out to infect variety of labora-
tory animals (like BALB/c mice, hamster) were 
not successful (Childs et al., 1984; Humber et al., 
1989; Akuffo et al., 1990). Later, Asrat Hailu et al. 
(1995) reported successful infection of grivet 
monkeys with L. aethiopica resulting in cutaneous 
leishmaniasis.   
 The aim of this project was identifying the 
suitable sites for Leishmania parasite inoculation 
in African green monkey to use them for further 
study for drug and vaccine trials in terms of 
accessibility and visibility for experimental 
outcome (for e.g., lesion development). In the 
previous study the inoculation of leishmania 
parasite was at the tip of the nose and earlobe 
(Asrat Hailu et al., 1995). In this experiment, the 
eye lid was tested as site of leishmania experi-
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mental infection since it is easy to observe the 
lesion in the eye lid while they are in their cage 
without shaving or catching monkeys. Infection 
at the tip of the nose is used as the control. It is a 
comparative study to assess skin lesions develop-
ment and progression in African green monkeys 
infected with L. aethiopica at the eye lid and tip of 
nose.   
 
 
MATERIALS AND METHODS 
 
Monkeys were trapped from Sodere and Meki 
(Leishmaniasis non–endemic areas in Central 
Ethiopia), and held in quarantine for 3 months to 
exclude natural Leishmania infection, SIV, 
hemoparasites, and intestinal parasites.   
 Isolates of L. aethiopica were obtained from LCL 
and DCL patients after inoculation of dermal 
scraping lesions in NNN medium. Primary 
isolates were further passaged into larger culture 
flasks of the same medium. A portion of the 
primary isolate freezed and thawed two weeks 
before the second phase of infection and put in 
NNN medium. Third passage stationary phase 
promastigotes were used for infection at a dose 
of 5 x 106 as described elsewhere (Rodriguez  et 
al., 2002). The strains were typed as L. aethiopica 
by isoenzyme electrophoresis. 
 The infection experiments were set in two 
phases. In the first phase, 8 monkeys were 
inoculated with an isolate obtained from a 
patient with LCL and 6 were inoculated subcuta-
neously with an isolate obtained from a patient 
with DCL. In the second phase (after two months 
of the first infection intiated), 8 monkeys were 
inoculated subcutaneously at the tip of the nose 
with the same dose of L. aethiopica promastigotes. 
In both cases a group of four control animals 
were inoculated with uninfected sterile of culture 
medium (Locks solution: an overlay for NNN 
medium). Each monkey in the experimental 
group was followed for two years. 
 During the follow–up, skin scrapings of lesions 
of the infected monkeys were taken from the 
edges of ulcerative lesions and nodules and 
aseptically transferred to NNN medium 
(Girginkardesler et al., 2001) and microscopic 
slide to confirm infection.  
 The study was approved by the Ethics Review 
Committee of the former Department of Biology 
at the College of Natural Sciences, Addis Ababa 
University (SF/Biol/343/91/99, 1999). Animal 
trapping was allowed by the Federal and 
Regional Forest and Wild Life Protection offices 
of the Ministry of Agriculture and Rural Devel-





Leishmania aethiopica inoculation at the eye lid of 
14 African green monkeys did not result in any 
skin lesions (Table 1). However, the inoculation 
of similar doses of the promastigotes (5x106) at 
the tip of the noses of 8 monkeys resulted in 
various stages of skin lesions (nodular and 
ulcerative) (Table 1). In four of the monkeys, the 
lesions result in ulcers at the inoculation sites. 
The uninfected control animals in both groups 
did not show any lesion development and 
remained healthy. Promastigotes were observed 
in NNN cultures medium of skin scraping taken 
from the ulcerative lesions. However, no 
parasites were observed in direct smear prepared 
from skin scraping. Inoculations of isolates 
obtained from LCL and DCL patients resulted in 
localized lesions. 
 







Type of strain 
No of monkeys with different clinical Manifestation 
Nodules & other 
clinical sign* 




 1( n=8) 0 0 0 
2( n=6) 0 0 0 
0( n=4) 0 0 0 
 
Phase 2 
3( n=6) 5(50-90)**  8 
2( n=2) 1(50-90)** 3(130-220)** 2 
0( n=4) 0 1 0 
 
Phase 1= Experimental infection of monkeys with L. aethiopica at the eye lid 
Phase 2= Experimental infection of monkeys with L. aethiopica at the tip of nose  
Strain type 1 = isolated from patient with localized cutaneous leishmaniasis (LCL)  
Strain type 2= isolated from patient with diffused cutaneous leishmaniasis 
*other clinical sign=hair lose, redness and indurations 
**the number in bracket is numbers of days starting from date of inoculation at which the particular clinical sign 
appear for the first time. 
+ - 12
 
13 14 15 1 2 3 4 5 6 8 9 




The results of this study are partially consistent 
with previous report by Asrat Hailu et al. (1995). 
In both studies African green monkeys develop 
nodular and/or ulcerative lesion in response to 
inoculation of 5 million Leishmania aethiopica at 
the tip of their nose. However, infection at the 
eye lid was not included in the previous study so 
no comparison could be done in this regard.  
 Leishmania aethiopica infection at the tip of the 
nose results in nodular and ulcerative lesions 
within 50–90 and 134–220 days, respectively. This 
result is similar to reports in humans since 
cutaneous leishmaniasis caused by L. aethiopica 
gives rise principally to localized cutaneous 
nodular lesions and ulceration is late or absent 
(WHO, 2010). Nylen and Eidsmo (2012) indicated 
that L. aethiopica is a parasite associated with slow 
disease progression and healing. However, there 
is no clinical sign in African green monkeys 
inoculated with same strain and similar dose of  
L. aethiopica parasites at the eye lid in contrast to 
inoculation of the same at the tip nose. This 
observation, may partially explain that host 
factor may also contribute in the restriction of 
Leishmania aethiopica infection in few sites of the 
body even though this is often attributed to the 
biting behavior of sand flies. Previously, it is also 
indicated that disease progression is affected by 
initial site of infection (Yetter et al., 1980). 
 There could be several possible host related 
factors that affect the lesion development in dif-
ferent parts of the body. Local immune responses 
like distribution of immune cells, cytokine profile 
and immune molecules such as inducible Nitro-
gen oxide (iNOS) could be one of those reasons. 
This agrees with the hypothesis that each organ 
may have a specific immune response (Alexan-
dre–Pires et al., 2010). Therefore importance of 
local immune response to pathogenesis of 
Leishmania infection is elucidated (Brachelente et 
al., 2005). As it was reviewed by Nylen and 
Eidsmo (2012), cutaneous leishmaniasis (CL) is 
caused by parasitic infection of dermal macro-
phages resulting in intense immune-mediated 
tissue inflammation and skin ulceration. There-
fore, different disease progression in different 
parts of the body may be caused by the distribu-
tion of immune cells such as macrophages, 
dendirtic cells and mast cells. Previous studies 
also suggest that clinical course of infection with 
Leishmania in humans is associated with specific 
local patterns of cytokine production (Pirmez et 
al., 1993, Brachelente et al., 2005). It was also 
reported that local iNOS expression is a marker of 
the leishmania resistant phenotype (Cangussu et 
al., 2009). The distribution of antimicrobial 
pepetides in the skin could also influence 
cutaneouse leishmaniasis disease progression as 
antimicrobial peptides and proteins (AP) can be 
induced in inflammatory lesions (Meyer et al., 
2007).  
 Detailed systematic study of the histological, 
immunological and parasitogical changes associ-
ated with L. aethiopica infection of C. aethiops is 
warranted for better understanding of some of 
the mechanisms involved in the control of infec-
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